Publication Cover
Physiotherapy Theory and Practice
An International Journal of Physical Therapy
Volume 39, 2023 - Issue 6
220
Views
0
CrossRef citations to date
0
Altmetric
Descriptive Reports

Graded peak cycle ergometer test for cognitively impaired patients with Parkinson’s disease: a pilot study

, BSc, PT, , PhD, , MSc, PT, , PhD, FACRM, , PhD & , PhD, PT
Pages 1249-1256 | Received 25 Feb 2021, Accepted 28 Dec 2021, Published online: 09 Feb 2022

References

  • American College of Sports Medicine 2010 ACSM’s Guidelines for Exercise Testing and Prescription. Philadelphia: Wilkins and L Williams.
  • Anderson HS, Kluding PM, Gajewski BJ, Donnelly JE, Burns JM 2011 Reliability of peak treadmill exercise tests in mild Alzheimer disease. International Journal of Neuroscience 121(8): 450–456. doi:10.3109/00207454.2011.574762
  • Billinger SA, Vidoni ED, Honea RA, Burns JM 2011 Cardiorespiratory response to exercise testing in individuals with Alzheimer’s disease. Archives of Physical Medicine and Rehabilitation 92(12): 2000–2005. doi:10.1016/j.apmr.2011.07.194
  • Bland MJ, Altman DG 1986 Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet 327(8476): 307–310. doi:10.1016/S0140-6736(86)90837-8
  • Borg GA 1982 Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise. 14: 377–381. doi:10.1249/00005768-198205000-00012
  • Bryant MS, Jackson GR, Hou JG, Protas E 2016 Treadmill exercise tests in persons with Parkinson’s disease: Responses and disease severity. Aging Clinical and Experimental Research 28(5): 1009–1014. doi:10.1007/s40520-015-0498-x
  • Dauwan M, Begemann MJ, Slot MI, Lee EH, Scheltens P, Sommer IE 2021 Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: A transdiagnostic systematic review and meta-analysis of randomized controlled trials. Journal of Neurology 268(4): 1222–1246. doi:10.1007/s00415-019-09493-9
  • DiFrancisco-Donoghue J, Elokda A, Lamberg EM, Bono N, Werner WG 2009 Norepinephrine and cardiovascular responses to maximal exercise in Parkinson’s disease on and off medication. Movement Disorders 24(12): 1773–1778. doi:10.1002/mds.22612
  • Dorsey ER, Bloem BR 2018 The Parkinson pandemic - A call to action. JAMA Neurology 75(1): 9–10. doi:10.1001/jamaneurol.2017.3299
  • Feng YS, Yang SD, Tan ZX, Wang MM, Xing Y, Dong F, Zhang F 2020 The benefits and mechanisms of exercise training for Parkinson’s disease. Life Sciences. 245: 117345. doi:10.1016/j.lfs.2020.117345
  • Fernandes B, Barbieri FA, Arthuso FZ, Silva FA, Moretto GF, Imaizumi LF, Ngomane AY, Guimarães GV, Ciolac EG 2019 High-Intensity interval versus moderate-intensity continuous training in individuals with Parkinson’s disease: Hemodynamic and functional adaptation. Journal of Physical Activity & Health. 17: 85–91. doi:10.1123/jpah.2018-0588
  • Fiorelli CM, Ciolac EG, Simieli L, Silva FA, Fernandes B, Christofoletti G, Barbieri FA 2019 Differential acute effect of high-intensity interval or continuous moderate exercise on cognition in individuals with Parkinson’s disease. Journal of Physical Activity & Health 16(2): 157–164. doi:10.1123/jpah.2018-0189
  • Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, et al. 2008 Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders. 23(15): 2129–2170. doi:10.1002/mds.22340
  • Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, et al. 2018 Cognitive impairment in Parkinson’s disease: A report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinson’s Disease. 4: 19. doi:10.1038/s41531-018-0055-3
  • Harvey M, Weston KL, Gray WK, O’Callaghan A, Oates LL, Davidson R, Walker RW 2019 High-intensity interval training in people with Parkinson’s disease: A randomized, controlled feasibility trial. Clinical Rehabilitation 33(3): 428–438. doi:10.1177/0269215518815221
  • Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG 2008 The Sydney Multicenter Study of Parkinson’s disease: The inevitability of dementia at 20 years. Movement Disorders. 23: 837–844. doi:10.1002/mds.21956
  • Hirsch MA, van Wegen EE, Newman MA, Heyn PC 2018 Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson’s disease: A systematic review and meta-analysis. Translational Neurodegeneration. 7: 7. doi:10.1186/s40035-018-0112-1
  • Hobson N, Dupuis SL, Giangregorio LM, Middleton LE 2020 Perceived facilitators and barriers to exercise among older adults with mild cognitive impairment and early dementia. Journal of Aging and Physical Activity 28(2): 208–218. doi:10.1123/japa.2019-0010
  • Hofmann P, Von Duvillard SP, Seibert FJ, Pokan R, Wonisch M, Lemura LM, Schwaberger G 2001 %HRmax target heart rate is dependent on heart rate performance curve deflection. Medicine and Science in Sports and Exercise. 33: 1726–1731. doi:10.1097/00005768-200110000-00017
  • Hughes AJ, Daniel SE, Kilford L, Lees AJ 1992 Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry. 55: 181–184. doi:10.1136/jnnp.55.3.181
  • Kalia LV, Lang AE 2015 Parkinson’s disease. The Lancet 386(9996): 896–912. doi:10.1016/S0140-6736(14)61393-3
  • Kanegusuku H, Silva-Batista C, Peçanha T, Nieuwboer A, Silva ND, Costa LA, De Mello MT, Piemonte ME, Ugrinowitsch C, Forjaz CL 2016 Blunted maximal and submaximal responses to cardiopulmonary exercise tests in patients with Parkinson disease. Archives of Physical Medicine and Rehabilitation 97(5): 720–725. doi:10.1016/j.apmr.2015.12.020
  • Katzel LI, Sorkin JD, MacKo RF, Smith B, Ivey FM, Shulman LM 2011 Repeatability of aerobic capacity measurements in Parkinson disease. Medicine and Science in Sports and Exercise 43(12): 2381–2387. doi:10.1249/MSS.0b013e31822432d4
  • Landers MR, Navalta JW, Murtishaw AS, Kinney JW, Richardson S 2019 A high-intensity exercise boot camp for persons with Parkinson disease: A Phase II, pragmatic, randomized clinical trial of feasibility, safety, signal of efficacy, and disease mechanisms. Journal of Neurologic Physical Therapy 43(1): 12–25. doi:10.1097/NPT.0000000000000249
  • Mavrommati F, Collett J, Franssen M, Meaney A, Sexton C, Dennis-West A, Betts JF, Izadi H, Bogdanovic M, Tims M, et al. 2017 Exercise response in Parkinson’s disease: Insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trial. BMJ Open. 7(12): e017194. doi:10.1136/bmjopen-2017-017194
  • Nadeau A, Lungu O, Duchesne C, Robillard MÈ, Bore A, Bobeuf F, Plamondon R, Lafontaine AL, Gheysen F, Bherer L, et al. 2017 A 12-week cycling training regimen improves gait and executive functions concomitantly in people with Parkinson’s disease. Frontiers in Human Neuroscience. 10: 690. doi:10.3389/fnhum.2016.00690
  • Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H 2005 The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 53: 695–699. doi:10.1111/j.1532-5415.2005.53221.x
  • Pedersen KF, Larsen JP, Tysnes OB, Alves G 2017 Natural course of mild cognitive impairment in Parkinson disease. Neurology. 88: 767–774. doi:10.1212/WNL.0000000000003634
  • Roberson KB, Signorile JF, Singer C, Jacobs KA, Eltoukhy M, Ruta N, Mazzei N, Buskard ANL 2019 Hemodynamic responses to an exercise stress test in Parkinson’s disease patients without orthostatic hypotension. Applied Physiology, Nutrition and Metabolism. 44: 751–758. doi:10.1139/apnm-2018-0638
  • Rogers JL, Howard KI, Vessey JT 1993 Using significance tests to evaluate equivalence between two experimental groups. Psychological Bulletin. 113: 553–565. doi:10.1037/0033-2909.113.3.553
  • Schenkman M, Moore CG, Kohrt WM, Hall DA, Delitto A, Comella CL, Josbeno DA, Christiansen CL, Berman BD, Kluger BM, et al. 2018 Effect of high-intensity treadmill exercise on motor symptoms in patients with De Novo Parkinson disease: A phase 2 randomized clinical trial. JAMA Neurology. 75(2): 219–226. doi:10.1001/jamaneurol.2017.3517
  • Siciliano M, De Micco R, Trojano L, De Stefano M, Baiano C, Passaniti C, De Mase A, Russo A, Tedeschi G, Tessitore A 2017 Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients. Parkinsonism & Related Disorders. 41: 86–91. doi:10.1016/j.parkreldis.2017.05.020
  • Snijders AH, Van Kesteren M, Bloem BR 2012 Cycling is less affected than walking in freezers of gait. Journal of Neurology, Neurosurgery, and Psychiatry 83(5): 575–576. doi:10.1136/jnnp-2011-300375
  • Speelman AD, Groothuis JT, Van Nimwegen M, Van Der Scheer ES, Borm GF, Bloem BR, Hopman MT, Munneke M 2012 Cardiovascular responses during a submaximal exercise test in patients with Parkinson’s disease. Journal of Parkinson’s Disease. 2: 241–247. doi:10.3233/JPD-2012-012111
  • Tanaka H, Monahan KD, Seals DR 2001 Age-predicted maximal heart rate revisited. Journal of the American College of Cardiology. 37: 153–156. doi:10.1016/S0735-1097(00)01054-8
  • van der Kolk NM, de Vries NM, Kessels RP, Joosten H, Zwinderman AH, Post B, Bloem BR 2019 Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: A double-blind, randomised controlled trial. Lancet Neurology. 18: 998–1008. doi:10.1016/S1474-4422(19)30285-6
  • van Wegen E, Hirsch MA, van de Berg WD, Rietberg MB, Vriend C, Newman M, Vanbellingen T, and van Den Heuvel OA 2020 High intensity interval cycle ergometer training in Parkinson’s disease: Protocol for identifying individual response patterns using a single subject research design. Frontiers in Neurology. 11: 1112. doi:10.3389/fneur.2020.569880
  • Werner WG, DiFrancisco-Donoghue J, Lamberg EM 2006 Cardiovascular response to treadmill testing in Parkinson disease. Journal of Neurologic Physical Therapy. 30: 68–73. doi:10.1097/01.NPT.0000282570.78544.00
  • Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA 2007 Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain. 130: 1787–1798. doi:10.1093/brain/awm111
  • Wonisch M, Berent R, Klicpera M, Laimer H, Marko C, Pokan R, Schmid P, Schwann H 2008 Praxisleitlinien ergometrie. Austrian Journal of Cardiology. 15: 3–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.